Evaluation of serum cytokine levels in toxic epidermal necrolysis and Stevens-Johnson syndrome compared with other delayed-type adverse drug reactions

Journal of Dermatology

Volumn 38, Issue 11, 2011, Pages 1076-1079

  Nomura, Yuki ^a   Aihara, Michiko ^a   Matsukura, Setsuko ^b   Ikezawa, Yuko ^b   Kambara, Takeshi ^b   Aihara, Yukoh ^b   Takahashi, Yukitoshi ^c   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE DRUG REACTION; APOPTOSIS; BODY SURFACE; CELL SURVIVAL; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DELAYED TYPE ADVERSE DRUG REACTION; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; EOSINOPHIL; ERYTHEMA MULTIFORME; GENE OVEREXPRESSION; HUMAN; KERATINOCYTE; LETTER; PAPULE; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG TOXICITY; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; STEVENS-JOHNSON SYNDROME; YOUNG ADULT;

EID: 80355146309     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01170.x     Document Type: Letter

References (11)

1. Bastuji-Garins S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96. (Pubitemid 23029676)
2. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE,. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1997; 130: 605-608.
3. Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 2008; 14: 1343-1350.
4. Konur A, Schulz U, Eissner G, Andreesen R, Holler E,. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol 2005; 152: 1134-1142. (Pubitemid 40933409)
5. Viard I, Wehri P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-493. (Pubitemid 28483679)
6. Rhodes LE, Hashim IA, MacLaughlin PJ, Friedmann PS,. Blister fluid cytokines in cutaneous inflammatory bullous disorders. Acta Derm Venereal 1999; 79: 288-290. (Pubitemid 29302057)
7. Nassif A, Moslehi H, Gouvello SL, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 2004; 123: 850-855. (Pubitemid 39391928)
8. Yamada H, Takamori K,. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan. Ther Apher Dial 2008; 12: 355-359.
9. Aihara Y, Ito S, Aihara M, Kobayasi Y, Yokota S,. Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reaction in a patient. Pediatr Int 2005; 47: 616-621. (Pubitemid 43951540)
10. Hirahara K, Kano Y, Mitsuyama R, Takahashi M, Kimishima M, Shiohara T,. Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions. Clin Exp Dermatol 2010; 35: 863-868.
11. de Vries JE,. The role of IL-13 and its receptor in allergic and inflammatory responses. J Allergy Clin Immunol 1998; 102: 165-169. (Pubitemid 28406898)